Core Viewpoint - Zhujiang Co., Ltd. plans to sell a total of 8.686 million shares of Guizhou Yibai Pharmaceutical Co., Ltd., 970,600 shares of Aorui De Optoelectronics Co., Ltd., 7,716 shares of China Ping An Insurance (Group) Co., Ltd., and 4.7122 million shares of Hunan Erkang Pharmaceutical Co., Ltd. to optimize its asset structure and improve liquidity and efficiency [1] Summary by Category Stock Sales - The company intends to sell 8.686 million shares of Guizhou Yibai Pharmaceutical [1] - The company plans to sell 970,600 shares of Aorui De Optoelectronics [1] - The company will sell 7,716 shares of China Ping An Insurance [1] - The company aims to sell 4.7122 million shares of Hunan Erkang Pharmaceutical [1] Financial Impact - The estimated profit from the stock sales, after deducting costs and taxes, is expected to exceed 50% of the company's audited net profit for the last year [1] Strategic Goals - The stock sales are aimed at optimizing the company's asset structure [1] - The initiative is intended to activate the company's existing assets [1] - The goal is to enhance the liquidity and efficiency of the company's assets [1]

格隆汇9月10日丨珠江股份(600684.SH)公布，公司计划根据市场行情出售所持868.60万股益佰制药股 票、97.06万股奥瑞德股票、7716股中国平安股票、471.22万股尔康制药股票。此次出售仅为初步意向， 能否成交及具体交易时间、价格存在不确定性。经初步测算，预计本次出售股票扣除持股成本及相关税 费后所获得收益将占公司最近一年经审计净利润50%以上，该事项尚需提交股东会审议。 ...

Group 1 - The company announced the resignation of director Yu Bin due to personal work reasons, and he will not hold any other positions within the company after his resignation [2][3] - Yu Bin's departure will not affect the minimum number of board members or the normal operations of the board, and the company will proceed with the election of a new director [3] - The board expressed gratitude for Yu Bin's contributions during his tenure, highlighting his diligence and commitment to the company's development [3] Group 2 - The company plans to sell up to 1.1 million shares of Yangtze Optical Fibre and Cable Joint Stock Limited Company, representing 0.15% of its total share capital, through a centralized bidding process [5][6] - As of the announcement date, the company holds 119,937,010 shares of Yangtze Optical Fibre, accounting for 15.82% of its total share capital [5][12] - The board approved the sale at a meeting held on September 4, 2025, with all 10 attending directors voting in favor [8][10] Group 3 - The sale of shares is intended to optimize the company's asset structure and improve capital efficiency, with the proportion of shares sold being small enough not to alter the company's holding status in Yangtze Optical Fibre [16] - The transaction does not constitute a related party transaction or a major asset restructuring as defined by regulations [7][10] - The company will follow legal procedures for the sale and will disclose information regarding the progress of the transaction as required [16]

Group 1 - The company plans to sell up to 1.1 million shares of Yangtze Communication's subsidiary, Yangtze Optical Fibre and Cable Joint Stock Limited Company, which represents 0.15% of the total share capital [1][3] - The company currently holds 119,937,010 shares of Yangtze Optical Fibre, accounting for 15.82% of its total share capital [2][4] - The board of directors approved the sale at the ninth meeting of the tenth board on September 4, 2025, and the transaction does not constitute a related party transaction or a major asset restructuring [1][4] Group 2 - The sale will be conducted through a centralized bidding process on the stock exchange, with the sale price determined by market conditions [3][5] - The estimated transaction amount is approximately 100.17 million yuan, with a book value of 16.68 million yuan for the shares being sold [3][5] - The authorization for the sale is valid for twelve months from the date of board approval [3][5] Group 3 - The transaction is expected to optimize the company's asset structure and improve capital efficiency, while the small proportion of shares sold will not change the company's holding status in Yangtze Optical Fibre [8] - The company will adjust the number of shares sold in case of any corporate actions such as dividends or stock splits during the authorization period [5][8] - The actual impact of the sale on the company's performance will be determined after accounting treatment in accordance with relevant accounting standards [8]

Core Viewpoint - The company plans to sell up to 4.5 million shares of Liaoning Aoke Chemical Co., Ltd. to maximize shareholder value and optimize asset structure [1] Group 1: Company Actions - The board of directors approved the proposal for the stock asset sale on June 12, 2025 [1] - The management and authorized personnel are empowered to handle the share sale within a 12-month authorization period [1] - The number of shares to be sold may change if Aoke shares undergo stock dividends or capital reserve increases [1] Group 2: Financial Implications - The transaction method and price will be determined based on the secondary market price trends [1] - The transaction amount and potential profits from the sale are currently undetermined [1]